DahlöfCWell-being (quality of life) in connection with hypertensive treatment.Clin Cardiol1991;14:97–103
2.
DimenäsEAspects of quality of life in hypertension: methods for evaluation.Gothenburg University,1990:1–67
3.
SpilkerB, ed.Quality of life assessments in clinical trials.New York:Raven Press,1990:1–470
4.
DahlöfCDimenäsEKendallMWiklundIQuality of life in cardiovascular diseases. Emphasis on beta-blocker treatment.Circulation1991;84(suppl 6):108–18
5.
DahlöfCHednerTThulinTGustafssonSOlssonSOEffects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.Eur J Clin Pharmacol1991;40:453–60
BradburnNMThe structure of physiological well-being.Chicago:Aldine,1969
8.
HuntSMMcKennaSPMcEvenJBackerEMWilliamsJPappEA quantitative approach to perceived health status: a validation study.J Epidemiol Community Health1981;35:297–300
9.
WiklundITibblinGDimenäsE, ed.Quality of life and hypertension-Definition and measurement of quality of life from a medical perspective. Scand J Prim Health Care1990(suppl 1):1–96
10.
CroogSHLevineSTestaMAThe effects of antihypertensive therapy on quality of life.N Engl J Med1986;314:1657–64
11.
FletcherAEBulpittCJHawkinsCMQuality of life on anti-hypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.J Hypertension1990;8:463–6
12.
SteinerSSFriedhoffAJWilsonBRWeckerJRSantoJPAntihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.J Human Hypertens1990;4:217–25
13.
DimenäsEDahlöfCJernSWiklundIDefining quality of life in medicine.Scand J Prim Health Care1990;l(suppl):7–10
14.
World Health Organization.World Health Organization Constitution Basic Documents. Geneva:1948
15.
CampbellACoversePERodgersWL,The quality of American life; perceptions, evaluations and satisfaction.New York:Russell Sage Foundation,1976
16.
NajmanJMLevineSEvaluating the impact of medical care and technologies on the quality of life: a review and critique.Soc Sci Med1981;15:107–15
17.
DahlöfCDimenäsEOlofssonBDocumentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.Cardiovasc Drugs Ther1989;3:919–27
18.
DahlöfC,Minor Symptoms Evaluation (MSE) Profile-a questionnaire for assessment of subjective CNS-related symptoms.Scand J Prim Health Care1990;1:19–25
19.
CarminesEGZellerRAReliability and validity assessment. In:SullivanJLNiemiRG, ed.Quantitative applications in the social sciences.Beverly Hills/London/New Delhi:Sage1983
20.
JachuckSJBrieleyHJachuckSWillcoxPMThe effect of hypotensive drugs on the quality of life.JR Coil Gen Pract1982;32:103–5
21.
GuyartGWalterSNormanGMeasuring change over time: assessing the usefulness of evaluative instruments.J Chron Dis1987;40:171–8
22.
DahlöfCBjörkmanRDiclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine.Cephalalgia1993;13:117–23
23.
DahlöfCEdwardsCTothASumatriptan injection is superior to placebo in the acute treatment of migraine- with regard to both efficacy and general well-being.Cephalalgia1992:12:214–20
24.
DahlöfCDimenäsEMigraine patients experience poorer subjective well-being also between the attacks.Cephalalgia1993(submitted)